Jefferson Healthcare Hospital is a 25-bed Critical Access Hospital located in Port Townsend, Washington. Established in 1890 by the Sisters of Providence as St. John Hospital, it is presently independently owned and operated by Jefferson County Public Hospital District No. 2, doing business as Jefferson Healthcare.

There are 25 beds in Jefferson Healthcare.

During the past decade, Jefferson Healthcare conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 23 clinical trials were completed, i.e. on average, 24.2% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 22 clinical trials were completed. i.e. 56.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jefferson Healthcare" #1 sponsor was "National Cancer Institute (NCI)" with 43 trials, followed by "SWOG Cancer Research Network" with 26 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Jefferson Healthcare" are "Invasive Breast Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials) and "Stage IVA Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Jefferson Healthcare" in a lesser frequency.

Most popular intervention types in "Jefferson Healthcare" are "Drug" (78 trials), "Other" (68 trials), "Biological" (50 trials), "Procedure" (37 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (30 trials), "Laboratory Biomarker Analysis" (28 trials), "Biospecimen Collection" (25 trials), "Computed Tomography" (23 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

The vast majority of trials in "Jefferson Healthcare" are 89 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jefferson Healthcare". undefined are not yet recruiting, 38 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Jefferson Healthcare, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Jefferson Healthcare, 1 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".